Medtronic's (Minneapolis) Ablation Frontiers (Carlsbad, California) could face a potential setback in a quest to gain significant share in the atrial fibrillation (AF) market, according to results of a study abstract that was published on the National Library of Medicine's website. (Medical Device Daily)